NCT02278835

Brief Summary

This trial was conducted to evaluate the effectiveness of the chest physiotherapy techniques to prevent pulmonary collapse based in an score applied in the patients submitted of the mitral valve surgery, after their ICU discharge. Patients were allocated in groups according their pulmonary function (FVC: forced vital capacity), the respiratory muscle performance (MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure), the oxygenation level (SpO2), the pulmonary auscultation; respiratory frequency (f); the ability to expectorate and the functional independence. The group I was allocated those patients which presented decrease of up to 50% of forced vital capacity (FVC) of preoperative period, SpO2\>92%, minimal pulmonary auscultation alterations; frequency (f) between 15 and 25 ipm; able to expectorate without assistance; independence to sit; respiratory. In these patients were randomized for two interventions: a) Deep breathing exercises: diaphragmatic exercises; inspiratory sighs; maximal inspiration exercises. Each kind of exercises was repeated 10 times; b) volume-targeted incentive spirometer: used Coach® three sets of 10 repetitions. Patients allocated in the group II presented FVC\> 30% \<49% of preoperative period, ≥ 88% SpO2 \<92%, necessity of oxygen therapy, abnormal pulmonary auscultation, f\> 25 \<31ipm; dependence to expectorate and to sit.. They were assisted by: a) Intermittent Positive Pressure Breathing (IPPB) with PEEP - through ventilator (Bird Mark 7™) with exhalation valve spring load set at 10 cmH2O. b) CPAP - 10 cmH2O associated with oxygen support to obtain SpO2≥ 95% with electronic device (Sullivan®) Each session consisted of 20 minutes, twice daily, one in the morning and another in the afternoon. All of the patients were conducted in effort to mobilize upper and lower limbs. On the first day, the patients walked at least 50 meters, by increasing the distance to at least 150 meters on the fourth day. Outcome measures were recorded at day 5 of the interventions.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2009

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 2, 2014

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 30, 2014

Completed
Last Updated

October 30, 2014

Status Verified

October 1, 2014

Enrollment Period

4.8 years

First QC Date

October 2, 2014

Last Update Submit

October 29, 2014

Conditions

Keywords

Cardiac valve

Outcome Measures

Primary Outcomes (1)

  • incidence of atelectasis

    Patients were followed for five days

Secondary Outcomes (3)

  • pulmonary function

    Patients were followed for five days

  • pulmonary function

    Patients were followed for five days

  • pulmonary function

    Patients were followed for five days

Other Outcomes (2)

  • Respiratory Muscle Strength

    Patients were followed for five days

  • Respiratory Muscle Strength

    Patients were followed for five days

Study Arms (2)

level1

OTHER

Patients classified in level 1 were randomized in the breathing exercises group or incentive spirometry group

Other: breathing exercisesDevice: incentive spirometry

level2

OTHER

Patients classified in level 2 were randomized in the Intermittent Positive Pressure Breathing group or Continuous Positive Airway Pressure group

Device: Intermittent positive pressure breathingDevice: Continuous positive airway pressure

Interventions

3 sets of 10 repetitions of deep breathing exercises

Also known as: EXE
level1

3 sets of 10 repetitions of deep breathing exercises with incentive spirometry

Also known as: IS (Coach®)
level1

20 minutes breathing with intermittent positive pressure

Also known as: IPPB (BIRD Mark 7™)
level2

20 minutes breathing with continuous positive airway pressure

Also known as: CPAP (Sullivan®)
level2

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients for mitral valve surgery, up to a maximum 2nd valve replacement

You may not qualify if:

  • Patients unable to perform the functional tests
  • Patients with signs of neurological disorders; hemodynamic instability, respiratory disorders and mechanically ventilated for more than 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Matte P, Jacquet L, Van Dyck M, Goenen M. Effects of conventional physiotherapy, continuous positive airway pressure and non-invasive ventilatory support with bilevel positive airway pressure after coronary artery bypass grafting. Acta Anaesthesiol Scand. 2000 Jan;44(1):75-81. doi: 10.1034/j.1399-6576.2000.440114.x.

    PMID: 10669276BACKGROUND
  • Pasquina P, Tramer MR, Walder B. Prophylactic respiratory physiotherapy after cardiac surgery: systematic review. BMJ. 2003 Dec 13;327(7428):1379. doi: 10.1136/bmj.327.7428.1379.

MeSH Terms

Interventions

Breathing ExercisesIntermittent Positive-Pressure BreathingContinuous Positive Airway Pressure

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy ModalitiesPositive-Pressure RespirationRespiration, ArtificialAirway ManagementRespiratory Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Drª Maria Ignez Zanetti Feltrim

Study Record Dates

First Submitted

October 2, 2014

First Posted

October 30, 2014

Study Start

March 1, 2009

Primary Completion

January 1, 2014

Study Completion

September 1, 2014

Last Updated

October 30, 2014

Record last verified: 2014-10